to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Angel investors have been banding together in groups, a development that benefits both the financiers and the companies they fund, says a former entrepreneur who chairs the nation's largest angel network.
Health IT, innovation and business models are some of the topics addressed in this Q&A session with Richard Foster, a new partner at venture capital firm Lux Capital. Read more for his views on the future of health IT and his advice for new entrepreneurs.
Question: I’ve read a few articles and blog posts over the past couple of days regarding Senator Dodd’s financial reform bill, and some of them suggest that it’s going to be more difficult for startups to raise money if the bill is signed into law. Why is that? I thought the bill was supposed to address the problems on Wall Street that led to our financial crisis.
The founder of a software development business had already agreed to be acquired by one company and was ready to sign the documents. Then another company came calling with a better offer. Loyal employees and a working partnership with the buyer turned out to be the crucial assets constituting the value of the business. The author concludes that you need to shop around and negotiate to find out what your company is really worth.
A new biomedical endowment at Duke University will support a program that has already launched new healthcare businesses. Read more to find out about Duke’s successes in commercializing medical technology.
The venture capital climate improved in RTP in the first quarter, but biotech companies are still competing for dollars. Several RTP companies saw venture capital investment for development of pharmaceutical products and medical technologies. Read more to learn about the venture capital climate.
Hatteras Venture Partners, a venture capital firm, will invest $20 million to $30 million in helping companies through first-in-man and preclinical studies. The firm expects to invest in 10 to 15 companies in the healthcare business.
A North Carolina startup is taking on the problem of counterfeit drugs. The company’s technology embeds a tiny tag into the medicine itself that allows for identification and authentication to fight fraudulent pharmaceuticals.
A startup company with a new way to make nanofibers sees many potential applications in the medical business. Xanofi has the technology to make strides in several industries, including the healthcare business.
At-the-market offerings are used for investing in other industries, but they are just starting to pick up in life science investing. Read more on what the healthcare business should know about ATM offerings.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.